The role of nitric oxide and other neurotransmitters in erectile function

Current Opinion in Urology

Volumn 6, Issue 6, 1996, Pages 347-351

  Pickard, Robert ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DOPAMINE; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; NORADRENALIN; OXYTOCIN; SEROTONIN;

CORPUS CAVERNOSUM; HUMAN; IMPOTENCE; MALE; PENIS ERECTION; PRIORITY JOURNAL; SHORT SURVEY; SMOOTH MUSCLE CONTRACTILITY;

EID: 0029964748     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199611000-00013     Document Type: Short Survey

References (47)

1. Lerner SE, Melman A, Christ GJ: A review of erectile dysfunction: new insights and more questions. J Urol 1993, 149:1246-1255.
2. Andersson K-E, Wagner G: Physiology of penile erection. Physiol Rev 1995, 75:191-236. Excellent comprehensive review of central and peripheral physiology by two of the leading researchers in this field.
3. Giuliano FA, Rampin O, Benoit G, Jardin A: Neural control of penile erection. Urol Clin North Am 1995, 22:747-766. Good clinically based review from a research group who have published extensively on the CNS basis of erection in the rat model.
4. Marson L, Platt KB, McKenna KE: Central nervous system innervation of the penis as revealed by the transneuronal transport of pseudorabies virus. Neuroscience 1993, 55:263-280.
5. Steers WD: Neural control of penile erection. Semin Urol 1990, 8:66-79.
6. Zarrindast MR, Shokravi S, Samini M: Opposite influences of dopaminergic receptor subtypes on penile erection. Gen Pharmacol 1992, 23:671-675.
7. Zarrindast MR, Farahvash H: Effects of GABA-ergic drugs on penile erection induced by apomorphine in rats. Psychopharmacology 1994, 115:249-253.
8. Argiolas A, Melis MR, Stancampiano R: Role of central oxytocinergic pathways in the expression of penile erection. Regul Pept 1993, 45:139-142.
9. 2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations. Eur J Pharmacol 1992, 229:9-14.
10. 1c receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission. Eur J Pharmacol 1994, 261:149-155.
11. Garthwaite J, Charles SL, Chess-Williams R: Endothelium -derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988, 336:385-388.
12. Southam E, Garthwaite J: The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 1993, 32:1267-1277.
13. Dawson VL, Dawson TM: Physiological and toxological actions of nitric oxide in the central nervous system. Adv Pharmacol 1995, 34:323-342.
14. Argiolas A: Nitric oxide as a central mediator of penile erection. Neuropharmacology 1994, 33:1339-1344.
15. 1c receptor agonists in male rats. Naunyn Schmiedebergs Arch Pharmacol 1995, 351:439-445.
16. Poggioli R, Benelli A, Arletti R, Cavazzuti E, Bertolini A: Nitric oxide is involved in the ACTH-induced behavioral syndrome. Peptides 1995, 16:1263-1268.
17. Eckhard C: Investigation of penile erection in the dog [in German]. Beit Anat Physiol 1863, 3:123-150.
18. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43:109-142.
19. Lincoln TM, Cornwell TL: Intracellular cyclic GMP receptor proteins. FASEB J 1993, 7:328-338.
20. Burnett AL: Role of nitric oxide in the physiology of erection. Biol Reprod 1995, 52:485-489.
21. Burnett AL, Saito S, Maguire MP, Yamaguchi H, Chang TSK, Hanley DF: Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia. J Urol 1995, 153:212-217. Well performed neuroanatomical study tracing NO-mediated neural connections from the pelvic plexus to the spinal cord in the rat.
22. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J: Nitric oxide and cyclic GMP formation upon electrical field stimulation of corpora cavernosum smooth muscle. Biochem Biophys Res Commun 1990, 170:843-850.
23. Pickard RS, Powell PH, Zar MA: Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum. Br J Urol 1995, 75:516-522.
24. Hayashida H, Okamura T, Tomoyoshi T, Toda N: Neurogenic nitric oxide mediates relaxation of canine corpus cavernosum. J Urol 1996, 155:1122-1127.
25. Moriel EZ, Gonzalez-Cadavid N, Ignarro LJ, Byrns R. Rajfer J: Levels of nitric oxide metabolites do not increase during penile erection. Urology 1993, 42:551-553.
26. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I: Oxygen tension regulates the nitric oxide pathway. J Clin Invest 1993, 91:437-442.
27. Kim N, Kim J, Hypolite J, Garcia-Diaz F, Broderick GA, Tornheim K, Daley J, Levin R, Saenz de Tejada I: Altered contractility of rabbit penile corpus cavernosum smooth muscle by hypoxia. J Urol 1996, 155:772-778.
28. Klotz T, Bloch W, Zumbe J, Vorreuther R, Heidenreich A, Engelmann U: Quantitative determination of nitric oxide synthase activity in the human corpus cavernosum in potent patients and in patients with impotence. Aktuel Urol 1995, 26:28-30.
29. Bernabe J, Meulemans A, Rampin O, Giuliano F. Biochemical evaluation of nitregic innervation of the rat penis, Int J Impot Res 1995, 8:S42. Interesting pilot study separating components of NOS activity in corpus cavernosum.
30. Elabbady A, Gagnon C, Hassouna M, Begin L, Elhilali M: Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats. Br J Urol 1995, 76:196-202.
31. Porst H: Prostaglandin E1 and the nitric oxide donor linsidomine for erectile failure: a diagnostic comparative study of 40 patients. J Urol 1993, 149:1280-1283.
32. Aoki H, Fujioka T, Matsuzaka J, Kubo T, Nakamura K, Yasuda N: Supression by prolactin of the electrically induced erectile response through its direct effect on the corpus cavernosum penis in the dog. J Urol 1995, 154:595-600.
33. Chen X, Lee TJ: Ginsenosides-induced nitric oxide-mediated relaxation of the rabbit corpus cavernosum. Br J Pharmacol 1995, 115:15-18. Well conducted and reported pharmacological study giving a possible mechanism of action for ginseng extracts in the treatment of sexual dysfunction.
34. Chamness SL, Ricker DD, Crone JK, Dembeck CL, Maguire MP, Burnett AL. Chang TSK: The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 1995, 63:1101-1107. Paper detailing changes in NOS activity throughout the male rat reproductive system following castration with significant reductions in penile NOS activity restored by testosterone.
35. Lugg JA, Rajfer J, Gonzalez-Cadavid N: Dihydrotestosterone is the active androgen in the maintenance of nitric-oxide-mediated penile erection in the rat Endocrinology 1995, 136:1495-1501. Important study showed that erection and NOS activity is decreased in rats following castration and restored by androgens. Finastende partially blocked the restorative effect of testosterone suggesting dihydrotestosterone may be active in this regard.
36. Trigo-Rocha F, Hsu G, Donatucci CF, Lue TF: The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and non-adrenergic, non-cholinergic neurotransmission in canine penile erection. J Urol 1993, 149:872-877.
37. Traish AM, Netsuwan N, Daley J, Padma-Nathan H, Goldstein I, Saenz de Tejada I: A heterogenous population of alpha-1 adrenergic receptors mediates contraction of human corpus cavemosum smooth muscle to norepinephrine. J Urol 1995, 153:222-227.
38. Christ GJ, Lerner SE, Kim DC, Melman A: Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips. J Urol 1995, 153:1998-2003.
39. Bell CRW, Sullivan ME, Dashwood MR, Muddle JR, Morgan RJ: The density and distribution of endothelin 1 and endothelin receptor subtypes in normal and diabetic rat corpus cavernosum. Br J Urol 1995, 76:203-207.
40. Christ GJ, Maayani S, Valcic M, Melman A. Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol 1990, 101:375-381.
41. Ding YQ, Takada M, Kaneko T, Mizuno N: Colocalization of vasoactive intestinal polypeptide and nitric oxide in penis-innervating neurones in the major pelvic ganglia of the rat. Neurosci Res 1995, 22:129-131.
42. Pickard RS, Powell PH, Zar MA: Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle. Br J Pharmacol 1993, 108:497-500.
43. Suh JK, Mun KH, Cho CK, Shin HC, Kim YS, Park TC: Effect of vasoactive intestinal polypeptide and acetylcholine on penile erection in the rat in vivo. Int J Impot Res 1995, 7:111-118.
44. Aoki H, Matsuzaka J, Yeh KH, Sato F, Fujioka T, Kubo T, Ohhori T, Yasuda N: Involvement of vasoactive intestinial polypeptide (VIP) as a humoral mediator of penile erectile function in the dog. J Androl 1994, 15:174-182.
45. Hedlund P, Alm P, Ekstrom P, Fahrenkrug J, Hannibal J, Hedlund H, Larsson B, Andersson K-E: Pituitary adenylate cyclase-activating peptide, helospectin and vasoactive intestinal polypeptide in human corpus cavernosum. Br J Pharmacol 1995, 116:2258-2266.
46. Saenz de Tejada I: Commentary on mechanisms for the regulation of penile smooth muscle contractility [Editorial]. J Urol 1995, 153:1762.
47. Ottesen B, Fahrenkrug J: Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in female and male genital tract: localization, biosynthesis and functional and clinical significance. Am J Obstet Gynecol 1995, 172:1615-1631.